ASX/SNT (ASX/SNT)

Australian Securities Exchange: ASX/SNT · AUD

A$0.02

+0.00 (+5.6%)· Recorded snapshot

Market cap	37.3M
Revenue (ttm)	6.9M
Net income (ttm)	-9M
EPS (ttm)	-A$0.01
Shares out	2B
Volume	15,000
Beta	0.24

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 6.9M
Net income (ttm): -9M
EPS (ttm): -A$0.01
Market cap: 37.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 14.6P50 21P75 31.9

Trailing P/En/a

P25 15.4P50 29.4P75 64.4

ROE-59.7

P25 -108P50 -50.6P75 1.1

ROIC-364.8

P25 -64.5P50 -33.5P75 0.8

Benchmarks · 1M

All ASX/SNT indicators

Market & fundamental data

Available fields

186

Groups with data

Currency

AUD

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-10-30
Employees	21
Employees change	-48
Employees growth	-69.57%
Enterprise value	AUD 23.7M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	1998
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	AU0000312480
Last earnings date	2026-07-28
Last refreshed	2026-10-29
Market cap	AUD 37.3M
Next earnings date	2026-10-30
Price	AUD 0.02
Price currency	AUD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-29
Symbol	asx/SNT
Website	https://syntaratx.com.au

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-28.57%
EV/Sales	3.42x
FCF / EV yield	-41.2%
FCF yield	-26.22%
P/B ratio	2.3x
P/S ratio	5.38x
Price / tangible book value	2.32x
Sector forward P/E	34.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-139.62%
EBITDA margin	-137.51%
Gross margin	-6.49%
Operating margin	-139.62%
Pretax margin	-138.71%
Profit margin	-129.78%
ROA	-29.81%
ROA (5Y)	-39.03%
ROCE	-59.47%
ROE	-59.65%
ROE (5Y)	-106.06%
ROIC	-364.76%
SBC / revenue	13.74%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	3
EPS growth years	0
Net income growth quarters	2
Net income growth years	0
Revenue growth	-5.03%
Revenue growth (Q)	-13.31%
Revenue growth (QoQ)	15.32%
Revenue growth 10Y	-3.21%
Revenue growth 3Y	3.61%
Revenue growth 5Y	-21.75%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -2,000
Depreciation and amortization	AUD 146,000
EBIT	AUD -9.7M
EBITDA	AUD -9.5M
EPS	AUD -0.01
FCF per share	AUD -0.00
Financing cash flow	AUD 8.3M
Free cash flow	AUD -9.8M
Free cash flow minus SBC	AUD -10.7M
Gross profit	AUD -450,000
Investing cash flow	AUD -2,000
Net cash flow	AUD -1.5M
Net income	AUD -9M
Operating cash flow minus SBC	AUD -10.7M
Operating income	AUD -9.7M
Revenue	AUD 6.9M
Stock-based compensation	AUD 952,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-19.56
Book value per share	AUD 0.01
Debt / equity	0
Interest coverage	-967.7
Long-term assets	AUD 330,000
Long-term liabilities	AUD 58,000
Net cash (debt)	AUD 13.6M
Net cash / market cap	36.36%
Net cash growth	-9.54%
Net debt / equity	-0.84
Piotroski F-Score	2
Property, plant and equipment	AUD 54,000
Shareholders' equity	AUD 16.2M
Tangible book value	AUD 16.1M
Tangible book value per share	AUD 0.01
Total assets	AUD 19.1M
Total cash	AUD 13.6M
Total debt	AUD 0
Total liabilities	AUD 2.9M
WACC	5.58%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.34
Current assets	AUD 18.8M
Current liabilities	AUD 2.9M
Current ratio	6.57
Net working capital	AUD 2.4M
Quick ratio	6.42
Working capital	AUD 15.9M
Working capital turnover	0.44

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-13.69%
Shareholder yield	-13.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-92.96%
10Y return CAGR	-23.31%
10Y total return	-92.96%
150-day SMA	AUD 0.03
15Y price change	-98.55%
15Y return CAGR	-24.34%
15Y total return	-98.48%
1D price change	5.56%
1M price change	-17.39%
1M total return	-17.39%
1W price change	-5%
1W total return	-5%
1Y price change	-34.48%
1Y return CAGR	-34.5%
1Y total return	-34.48%
20-day SMA	AUD 0.02
200-day SMA	AUD 0.03
20Y price change	-99.34%
20Y return CAGR	-22.04%
20Y total return	-99.31%
3M price change	-13.64%
3M total return	-13.64%
3Y price change	-42.42%
3Y return CAGR	-16.8%
3Y total return	-42.42%
50-day SMA	AUD 0.02
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 0.04
52-week high date	2026-02-11
52-week low	AUD 0.02
52-week low date	2026-10-28
5Y price change	-84.8%
5Y return CAGR	-31.4%
5Y total return	-84.8%
6M price change	-40.63%
6M total return	-40.63%
All-time high	AUD 4.53
All-time high date	2007-11-01
All-time low	AUD 0.01
All-time low date	2024-04-22
Average true range (ATR)	AUD 0.00
Average volume	2.1M
Beta (1Y)	1.46
Beta (2Y)	1.65
Beta (5Y)	0.24
Change from 52-week high	-47.22%
Change from 52-week low	5.56%
Change from all-time high	-99.58%
Change from all-time low	35.71%
Change from open	0%
Day's gap	5.56%
Dollar volume	AUD 285
High price	AUD 0.02
Low price	AUD 0.02
Monthly RSI	38.38
Open price	AUD 0.02
Previous close	AUD 0.02
Price vs 150-day SMA	-24.9%
Price vs 20-day SMA	-9.52%
Price vs 200-day SMA	-29.89%
Price vs 50-day SMA	-17.75%
Relative volume	0.01
RSI	40.56
Sharpe ratio	-0.2
Sharpe ratio (3Y)	0.25
Sharpe ratio (5Y)	-0.07
Sortino ratio	-0.21
Sortino ratio (3Y)	0.43
Sortino ratio (5Y)	-0.03
Volume	15K
Weekly RSI	39.38
YTD price change	-45.71%
YTD total return	-45.71%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.5B
Shares change (QoQ)	5.28%
Shares change (YoY)	13.69%
Shares held by insiders	1.89%
Shares held by institutions	7.83%
Shares outstanding	2B

Deeper analysis on ASX/SNT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/SNT report

Is a complete ASX/SNT research report available?

No complete published report is available for asx/SNT (ASX/SNT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/SNT (ASX/SNT)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/SNT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/SNT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/SNT

Frequently asked questions